BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8381394)

  • 1. The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells.
    Reiter LS; Kruithof EK; Cajot JF; Sordat B
    Int J Cancer; 1993 Feb; 53(3):444-50. PubMed ID: 8381394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator.
    Tran-Thang C; Vouillamoz D; Kruithof EK; Sordat B
    J Cell Physiol; 1994 Nov; 161(2):285-92. PubMed ID: 7962113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
    Cajot JF; Bamat J; Bergonzelli GE; Kruithof EK; Medcalf RL; Testuz J; Sordat B
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):6939-43. PubMed ID: 2169614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.
    Lansink M; Koolwijk P; van Hinsbergh V; Kooistra T
    Blood; 1998 Aug; 92(3):927-38. PubMed ID: 9680361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
    Quax PH; de Bart AC; Schalken JA; Verheijen JH
    Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
    Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
    J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.
    Quax PH; Pedersen N; Masucci MT; Weening-Verhoeff EJ; Danø K; Verheijen JH; Blasi F
    Cell Regul; 1991 Oct; 2(10):793-803. PubMed ID: 1666303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
    Ronday HK; Smits HH; Quax PH; van der Pluijm G; Löwik CW; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1997 Jan; 36(1):9-15. PubMed ID: 9117184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells.
    Grimsley PG; Normyle JF; Brandt RA; Joulianos G; Chesterman CN; Hogg PJ; Owensby DA
    Thromb Res; 1995 Aug; 79(4):353-61. PubMed ID: 7482438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells.
    Cohen RL; Xi XP; Crowley CW; Lucas BK; Levinson AD; Shuman MA
    Blood; 1991 Jul; 78(2):479-87. PubMed ID: 1648983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
    Cajot JF; Schleuning WD; Medcalf RL; Bamat J; Testuz J; Liebermann L; Sordat B
    J Cell Biol; 1989 Aug; 109(2):915-25. PubMed ID: 2503527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
    Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells.
    Díaz VM; Hurtado M; Kort EJ; Resnati M; Blasi F; Thomson T; Paciucci R
    Exp Cell Res; 2006 Jul; 312(12):2203-13. PubMed ID: 16631161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1.
    Bruckner A; Filderman AE; Kirchheimer JC; Binder BR; Remold HG
    Cancer Res; 1992 Jun; 52(11):3043-7. PubMed ID: 1375533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.
    Hagège J; Peraldi MN; Rondeau E; Adida C; Delarue F; Medcalf R; Schleuning WD; Sraer JD
    Am J Pathol; 1992 Jul; 141(1):117-28. PubMed ID: 1632457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
    J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.